Hormel Foods Corporation
0J5Z.L
$23.84 -2.30%
Exchange: LSE | Sector: Consumer Defensive | Industry: Packaged Foods
Q4 2025
Published: Dec 5, 2025

Earnings Highlights

  • Revenue of $3.19B up 1.5% year-over-year
  • EPS of $-0.10 decreased by 125% from previous year
  • Gross margin of 14.0%
  • Net income of -56.14M
  • ""We recognize these results are well below our initial expectations for the year, but as Jeff mentioned, we have laid a solid foundation for a return to growth in fiscal 2026."" - Paul Keenan
0J5Z.L
Company 0J5Z.L

Executive Summary

Hormel Foods delivered a challenging QQ4 2025, capping a year marked by elevated commodity input costs and select operational disruptions. Q4 revenue reached $3.19B with a gross margin of 13.96%, but the quarter produced a net loss of $56.1M and a diluted EPS of -$0.10, reflecting margin pressures from pork, beef, and nut inflation, plus two non-operational events (a chicken recall and a Little Rock facility fire) that together shaved approximately 3 cents of EPS. For the full year, Hormel posted net sales above $12B with 2% organic growth, generating an adjusted operating income of just over $1B and an adjusted diluted EPS of $1.37, while GAAP operating income was $719M and GAAP diluted EPS was $0.87. The company closed 2025 with $805M of cash flow from operations, capex of $311M, and a year-end inventory position of $1.7B. Hormel also returned a record $633M to shareholders in dividends and raised the quarterly dividend by 1% to an implied annual rate of $1.17 per share for 2026, maintaining its dividend aristocrat pedigree. Management framed 2026 guidance around a balanced protein-centric portfolio, expecting 1-4% organic net sales growth and 4-10% adjusted operating income growth, with adjusted EPS guidance of $1.43-$1.51. They highlighted ongoing benefits from the Transform & Modernize initiative, continued portfolio reshaping (including Justin’s strategic partnership and noncore exits), and a sharpened emphasis on marketing efficiency and real-time commodity risk management. Risks remain tied to commodity cost volatility, turkey supply constraints, beef/nut cost headwinds, and macro consumer weakness. Overall, the investment thesis rests on a resilient, protein-focused brand ecosystem, improving margins via mix, pricing discipline, and ongoing productivity programs, alongside meaningful cash flow generation and a durable dividend yield.

Key Performance Indicators

Revenue
Increasing
3.19B
QoQ: 5.04% | YoY: 1.52%
Gross Profit
Decreasing
444.84M
13.96% margin
QoQ: -8.71% | YoY: -14.66%
Operating Income
Decreasing
2.17M
QoQ: -99.09% | YoY: -99.26%
Net Income
Decreasing
-56.14M
QoQ: -130.55% | YoY: -125.49%
EPS
Decreasing
-0.10
QoQ: -130.30% | YoY: -125.00%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 3,185.66 -0.10 +1.5% View
Q3 2025 3,032.88 0.33 -3.4% View
Q2 2025 2,898.81 0.33 +0.0% View
Q1 2025 2,988.81 0.31 +3.5% View
Q4 2024 3,138.09 0.40 +8.7% View